Rapid Medical Diagnostic Kits Market, by Technology (Lateral Flow, Agglutination Assays, Flow-Through, Solid-phase (“dipstick†assays)), By Application (Clinical testing (Infectious disease testing, Cholesterol monitoring, Substance abuse testing, Fer
Description
Rapid Medical Diagnostic Kits Market, by Technology (Lateral Flow, Agglutination Assays, Flow-Through, Solid-phase (“dipstick†assays)), By Application (Clinical testing (Infectious disease testing, Cholesterol monitoring, Substance abuse testing, Fertility & Pregnancy testing, Blood Glucose testing), Home-use (Blood glucose monitoring, Fertility & pregnancy testing, Cholesterol monitoring, Infectious disease, Substance abuse testing), By End User (Hospitals, Diagnostic Laboratories, Home-Care Settings, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Rapid Medical Diagnostic Kits comprises rapid antibody test and rapid antigen tests. Rapid antibody tests are used for HIV test and rapid plasma regain, whereas rapid antigen tests include, rapid influenza diagnostic test, malaria antigen detection tests, rapid strep test, and rapid urease test. Increasing prevalence of infectious diseases along with increasing Approval and launch of new tests is expected to propel growth of the global rapid medical diagnostic kits market over the forecast period. Moreover, increasing awareness regarding hepatitis, and increasing funding for R&D of new rapid tests is also expected to assist the market growth.
Key features of the study:
This report provides in-depth analysis of the Global Rapid Medical Diagnostic Kits market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Rapid Medical Diagnostic Kits market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abaxis, Inc., Abbott Laboratories, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter), LabCorp, MegaCor Diagnostik GmbH, F. Hoffmann-La Roche Ltd., Trinity Biotech plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Rapid Medical Diagnostic Kits market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Rapid Medical Diagnostic Kits market
Detailed Segmentation:
Global Rapid Medical Diagnostic Kits Market, By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
Global Rapid Medical Diagnostic Kits Market, By Application:
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
Global Rapid Medical Diagnostic Kits Market, By Region:
North America
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
U.S.
Canada
Latin America
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
North Africa
Central Africa
South Africa
Company Profiles
Abaxis Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Abbott Laboratories, Inc.
Becton, Dickinson & Company
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter)
LabCorp
MegaCor Diagnostik GmbH
F. Hoffmann-La Roche Ltd
Trinity Biotech plc.
“*” marked represents similar segmentation in other categories in the respective section.
Rapid Medical Diagnostic Kits comprises rapid antibody test and rapid antigen tests. Rapid antibody tests are used for HIV test and rapid plasma regain, whereas rapid antigen tests include, rapid influenza diagnostic test, malaria antigen detection tests, rapid strep test, and rapid urease test. Increasing prevalence of infectious diseases along with increasing Approval and launch of new tests is expected to propel growth of the global rapid medical diagnostic kits market over the forecast period. Moreover, increasing awareness regarding hepatitis, and increasing funding for R&D of new rapid tests is also expected to assist the market growth.
Key features of the study:
This report provides in-depth analysis of the Global Rapid Medical Diagnostic Kits market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Rapid Medical Diagnostic Kits market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abaxis, Inc., Abbott Laboratories, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter), LabCorp, MegaCor Diagnostik GmbH, F. Hoffmann-La Roche Ltd., Trinity Biotech plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Rapid Medical Diagnostic Kits market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Rapid Medical Diagnostic Kits market
Detailed Segmentation:
Global Rapid Medical Diagnostic Kits Market, By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
Global Rapid Medical Diagnostic Kits Market, By Application:
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
Global Rapid Medical Diagnostic Kits Market, By Region:
North America
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
U.S.
Canada
Latin America
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Type:
Lateral flow
Agglutination assays
Flow-through
Solid-phase (“dipstick” assays)
By Application
Clinical testing
Infectious disease testing
Cholesterol monitoring
Substance abuse testing
Fertility & Pregnancy testing
Blood Glucose testing
Home-use
Blood glucose monitoring
Fertility & pregnancy testing
Cholesterol monitoring
Infectious disease
Substance abuse testing
Veterinary
By Country
North Africa
Central Africa
South Africa
Company Profiles
Abaxis Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Abbott Laboratories, Inc.
Becton, Dickinson & Company
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter)
LabCorp
MegaCor Diagnostik GmbH
F. Hoffmann-La Roche Ltd
Trinity Biotech plc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
155 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product Launches
- 4. Global Rapid Medical Diagnostic Devices Market, By Technology, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Lateral Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Agglutination Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Flow-Through
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Biosensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 5. Global Rapid Medical Diagnostic Devices Market, By Application, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Cardio Metabolic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Nephrology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Drugs of Abuse (DoA) Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Blood Glucose Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Pregnancy Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Cancer Biomarker Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 6. Global Rapid Medical Diagnostic Devices Market, By End User, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Home-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 7. Global Rapid Medical Diagnostic Devices Market, By Regions, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- North America
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
- Africa
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- 8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Danaher Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Acon Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffman-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson, and Company
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trinity Biotech Plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 9. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 41 market data tables and 27 figures on "Rapid Medical Diagnostic Devices Market - Global forecast to 2028”.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
